Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.08+0.07 (+2.33%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
Whitehawk Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Whitehawk Therapeutics's profit margin for the twelve months ending Dec 31, 2025 was -288.3%. For fiscal 2025 it was -288.3%, against -245.1% the year before. The highest annual figure on record is -24.8% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -288.3% | −43.1 |
| FY2024 | Dec 31, 2024 | -245.1% | +24.9 |
| FY2023 | Dec 31, 2023 | -270.0% | +127.7 |
| FY2022 | Dec 31, 2022 | -397.7% | +388.7 |
| FY2021 | Dec 31, 2021 | -786.4% | −761.5 |
| FY2020 | Dec 31, 2020 | -24.8% | +26.7 |
| FY2018 | Dec 31, 2018 | -51.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | 1021.9% | +1363.6 |
| Q4 FY2024 | Dec 31, 2024 | -252.4% | +4.8 |
| Q3 FY2024 | Sep 30, 2024 | -174.0% | +99.6 |
| Q2 FY2024 | Jun 30, 2024 | -236.0% | +53.8 |
| Q1 FY2024 | Mar 31, 2024 | -341.7% | −82.2 |
| Q4 FY2023 | Dec 31, 2023 | -257.2% | +9.0 |
| Q3 FY2023 | Sep 30, 2023 | -273.6% | +67.4 |
| Q2 FY2023 | Jun 30, 2023 | -289.8% | +241.8 |
| Q1 FY2023 | Mar 31, 2023 | -259.5% | +341.2 |
| Q4 FY2022 | Dec 31, 2022 | -266.2% | −151.0 |
| Q3 FY2022 | Sep 30, 2022 | -341.0% | +4222.4 |
| Q2 FY2022 | Jun 30, 2022 | -531.5% | −590.6 |
| Q1 FY2022 | Mar 31, 2022 | -600.7% | +651.3 |
| Q4 FY2021 | Dec 31, 2021 | -115.2% | −80.0 |
| Q1 FY2021 | Mar 31, 2021 | -4563.3% | +392758.9 |
| Q4 FY2020 | Dec 31, 2020 | 59.1% | −2.2 |
| Q3 FY2020 | Sep 30, 2020 | -1251.9% | −802.7 |
| Q2 FY2020 | Jun 30, 2020 | -35.2% | – |
| Q4 FY2018 | Dec 31, 2018 | -397322.2% | – |
| Q3 FY2018 | Sep 30, 2018 | 61.3% | – |
| Q2 FY2018 | Jun 30, 2018 | -449.2% | – |
See a number that looks wrong?